Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||
Goods sale service render cash | 314.01%104.9M | 465.72%364.36M | 812.46%242.91M | 619.14%97.23M | 288.73%25.34M | 109.74%64.41M | 54.05%26.62M | 65.82%13.52M | 99.38%6.52M | -46.02%30.71M |
Refunds of taxes and levies | --0 | -3.45%228.03K | 26.68%228.03K | 26.68%228.03K | 18,263.48%34.83K | --236.18K | 3,278.51%180K | 54,824.24%180K | --189.67 | --0 |
Net deposit increase | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net increase in borrowings from central bank | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net increase in placements from other financial institutions | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Cash received from interests, fees and commissions | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net increase in repurchase business capital | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Premiums received from original insurance contracts | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net cash received from reinsurance business | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net increase in deposits from policyholders | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net increase in funds disbursed | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net cash received from trading securities | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Cash received relating to other operating activities | 28.92%2.17M | -60.80%9.18M | -69.56%6.55M | -81.81%3.53M | 45.77%1.68M | 169.93%23.41M | 1,712.50%21.51M | 6,203.70%19.4M | 385.62%1.16M | 214.89%8.67M |
Cash inflows from operating activities | 295.73%107.07M | 324.50%373.76M | 416.82%249.68M | 205.12%100.99M | 252.58%27.06M | 123.59%88.05M | 161.53%48.31M | 291.14%33.1M | 118.81%7.67M | -33.97%39.38M |
Goods services cash paid | 158.64%62.91M | 818.54%416.63M | 1,847.07%280.64M | 3,375.13%143.3M | 17,230.79%24.32M | 592.94%45.36M | 126.41%14.41M | 2,612.23%4.12M | -4.24%140.35K | -85.92%6.55M |
Staff behalf paid | 19.12%5.75M | 33.70%15.68M | 29.99%11.77M | 36.62%7.88M | 42.35%4.82M | 60.84%11.73M | 128.04%9.05M | 197.73%5.77M | 201.18%3.39M | -13.03%7.29M |
All taxes paid | 6.37%622.34K | 10.86%3.9M | 22.93%1.77M | 40.54%1.17M | 15.95%585.07K | -61.62%3.52M | -79.28%1.44M | -86.68%830.68K | -46.48%504.57K | -49.09%9.17M |
Net loan and advance increase | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net deposit in central bank and institutions | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net lend capital | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Cash paid for fees and commissions | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Cash paid for indemnity of original insurance contract | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Policy dividend cash paid | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Cash paid relating to other operating activities | -5.90%5.14M | 13.90%9.53M | 77.14%14.05M | 77.77%8.79M | 106.38%5.46M | 154.65%8.37M | 168.53%7.93M | 123.57%4.95M | 118.35%2.65M | -54.67%3.29M |
Cash outflows from operating activities | 111.44%74.42M | 546.25%445.74M | 838.72%308.22M | 928.48%161.14M | 426.77%35.2M | 162.34%68.97M | 62.33%32.83M | 48.65%15.67M | 94.97%6.68M | -67.19%26.29M |
Net cash flows from operating activities | 501.17%32.65M | -477.37%-71.98M | -478.24%-58.54M | -445.11%-60.15M | -920.19%-8.14M | 45.76%19.07M | 982.41%15.48M | 938.72%17.43M | 1,137.59%992.4K | 163.85%13.09M |
Investing cash flow | ||||||||||
Cash received from disposal of investments | -93.02%46.33M | -33.51%1.38B | -17.93%1.21B | 3.00%1.04B | 36.30%664.12M | 20.71%2.08B | 115.22%1.47B | 114.19%1.01B | 142.02%487.24M | 129.32%1.72B |
Cash received from returns on investments | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | ---- |
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | --0 | --0 | --0 | --0 | --0 | -28.86%15.93M | -28.86%15.93M | --6M | --0 | --22.4M |
Net cash received from disposal of subsidiaries and other business units | ---- | --0 | ---- | ---- | --0 | --0 | --0 | --0 | --0 | -88.20%3.5M |
Cash received relating to other investing activities | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 |
Cash inflows from investing activities | -93.02%46.33M | -34.02%1.38B | -18.81%1.21B | 2.39%1.04B | 36.30%664.12M | 19.83%2.1B | 109.86%1.49B | 114.96%1.01B | 142.02%487.24M | 123.93%1.75B |
Cash paid to acquire fixed assets intangible assets and other long-term assets | --159.66K | 619,856.24%39.92M | --38.97M | --38.71M | --0 | --6.44K | --0 | --0 | ---- | --0 |
Cash paid to acquire investments | -87.94%66.45M | -53.28%1.01B | -33.15%1.01B | 0.97%949.53M | 11.98%551M | 19.83%2.16B | 99.35%1.51B | 81.63%940.45M | 93.13%492.05M | 134.55%1.8B |
Net cash paid to acquire subsidiaries and other business units | ---- | --0 | ---- | ---- | --0 | --0 | --0 | --0 | --0 | --0 |
Impawned loan net increase | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Cash paid relating to other investing activities | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 |
Cash outflows from investing activities | -87.91%66.61M | -51.43%1.05B | -30.56%1.05B | 5.08%988.24M | 11.98%551M | 19.83%2.16B | 99.55%1.51B | 81.63%940.45M | 93.13%492.05M | 134.54%1.8B |
Net cash flows from investing activities | -117.93%-20.28M | 658.09%335.78M | 1,209.39%164.84M | -31.84%50.34M | 2,451.06%113.12M | -19.75%-60.17M | 66.35%-14.86M | 260.82%73.85M | 91.00%-4.81M | -460.59%-50.24M |
Financing cash flow | ||||||||||
Cash received from capital contributions | --0 | -99.23%490K | --490K | ---- | ---- | --63.84M | ---- | ---- | ---- | --0 |
-Including: Cash received from capital contributions by minority shareholders of subsidiaries | --490K | --490K | --490K | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Cash from borrowing | --0 | --10M | --10M | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Cash received relating to other financing activities | --0 | --0 | --0 | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Cash inflows from financing activities | --0 | -83.57%10.49M | --10.49M | ---- | ---- | --63.84M | ---- | ---- | ---- | --0 |
Borrowing repayment | --0 | --0 | ---- | ---- | --0 | --0 | ---- | ---- | ---- | ---- |
Dividend interest payment | --70.01K | --64.56K | ---- | ---- | --0 | --0 | ---- | ---- | ---- | ---- |
-Including:Cash payments for dividends or profit to minority shareholders | --0 | --0 | ---- | ---- | --0 | --0 | ---- | ---- | ---- | ---- |
Cash payments relating to other financing activities | -70.22%153.31K | 2,790.23%266.01M | 5,695.18%111.19M | -65.57%641.44K | --514.74K | -25.93%9.2M | -73.63%1.92M | --1.86M | --0 | -92.33%12.43M |
Cash outflows from financing activities | -56.62%223.32K | 2,790.93%266.07M | 5,695.18%111.19M | -65.57%641.44K | --514.74K | -25.93%9.2M | -73.63%1.92M | --1.86M | --0 | -92.33%12.43M |
Net cash flows from financing activities | 56.62%-223.32K | -567.79%-255.58M | -5,148.44%-100.7M | 65.57%-641.44K | ---514.74K | 539.72%54.64M | 73.63%-1.92M | ---1.86M | --0 | -121.49%-12.43M |
Net cash flow | ||||||||||
Exchange rate change effecting cash and cash equivalents | -207.29%-377.93 | -3.32%3.53K | -133.56%-2.24K | -82.82%1.42K | 112.13%352.26 | -80.41%3.65K | -71.10%6.67K | -22.84%8.25K | -231.56%-2.9K | 472.21%18.64K |
Net increase in cash and cash equivalents | -88.37%12.15M | -39.30%8.22M | 532.92%5.6M | -111.69%-10.45M | 2,833.30%104.47M | 127.33%13.55M | 97.57%-1.29M | 286.35%89.43M | 92.84%-3.82M | -196.70%-49.56M |
Add:Begin period cash and cash equivalents | 37.42%30.2M | 160.78%21.97M | 160.78%21.97M | 160.78%21.97M | 160.78%21.97M | -85.47%8.43M | -85.47%8.43M | -85.47%8.43M | -85.47%8.43M | 760.80%57.99M |
End period cash equivalent | -66.51%42.34M | 37.42%30.2M | 286.59%27.57M | -88.23%11.52M | 2,646.46%126.44M | 160.78%21.97M | 47.74%7.13M | 878.51%97.85M | -0.38%4.6M | -85.47%8.43M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Beijing Guofu Jiaying Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Asia Pacific (Group) Accounting Firm (Special General Partnership) | -- | -- | -- | Asia Pacific (Group) Accounting Firm (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.